Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant

Ana Maria Rivera1, Helen W Boucher

  • 1Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, MA 02111, USA.

Mayo Clinic Proceedings
|December 3, 2011
PubMed

Insights

Resistant gram-positive bacteria, including MRSA and VRE, cause severe infections, particularly in healthcare settings. Effective treatment requires antibiotic stewardship and stringent infection control to combat rising antimicrobial resistance.

Area of Science:

  • Infectious Diseases
  • Microbiology
  • Public Health

Background:

  • Gram-positive bacteria are significant causes of disease in diverse patient populations.
  • Antimicrobial resistance in these pathogens, especially in healthcare settings, leads to substantial morbidity and mortality.
  • Emerging resistance patterns, such as Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant enterococci (VRE), complicate treatment strategies.

Purpose of the Study:

  • To review the challenges posed by drug-resistant gram-positive bacterial infections.
  • To highlight the impact of resistance on treatment choices for common infections like pneumonia and skin infections.
  • To emphasize the importance of antimicrobial stewardship and infection control.

Main Methods:

  • Literature review of current research on gram-positive bacterial resistance.
  • Analysis of epidemiological trends in nosocomial and community-acquired infections.
  • Synthesis of treatment guidelines and recommendations for resistant pathogens.

Main Results:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a global concern for both hospital-acquired and community-acquired infections.
  • Penicillin-resistant Streptococcus pneumoniae complicates the treatment of respiratory tract infections due to resistance to beta-lactam and macrolide drugs.
  • Vancomycin-resistant enterococci (VRE) are prevalent in hospitals and resistant to most standard antibiotics.

Conclusions:

  • Effective management of diseases caused by resistant gram-positive bacteria necessitates judicious antibiotic use and stewardship programs.
  • Aggressive infection control measures are crucial for preventing the transmission of resistant strains.
  • A multifaceted approach combining antimicrobial stewardship and infection control is vital to preserve antibiotic effectiveness.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...